Terms: = Uterine cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
175 results:
1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the pi3k/Akt pathway through targeted inhibition of TPX2 in endometrial cancer.
Yang M; Mao X; Li L; Yang J; Xing H; Jiang C
Cancer Med; 2024 Mar; 13(5):e6958. PubMed ID: 38466034
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
4. Integrated genomic and transcriptomic analysis reveals the activation of pi3k signaling pathway in HPV-independent cervical cancers.
Wang Y; He M; He T; Ouyang X; Shen X; Shi W; Huang S; Xiang L; Zou D; Jiang W; Yang H
Br J Cancer; 2024 Apr; 130(6):987-1000. PubMed ID: 38253702
[TBL] [Abstract] [Full Text] [Related]
5. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/pi3k/AKT axis and VEGF-C secretion.
Mei X; Xiong J; Liu J; Huang A; Zhu D; Huang Y; Wang H
Cancer Lett; 2024 Mar; 584():216609. PubMed ID: 38211648
[TBL] [Abstract] [Full Text] [Related]
6. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer.
Hu Y; Jiang N; Wang X; Wu X; Bo J; Chen Y; Zeng Y; Wei X; Zhang H; Li M
Life Sci; 2024 Feb; 338():122389. PubMed ID: 38160786
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
[TBL] [Abstract] [Full Text] [Related]
8. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract] [Full Text] [Related]
9. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the pi3k/AKT pathway.
Chen R; Fang T; Liu N; Shi X; Wang J; Yu H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238
[TBL] [Abstract] [Full Text] [Related]
10. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
11. Genomic profile of Chinese patients with endometrial carcinoma.
Li J; Li X; Quan C; Li X; Wan C; Wu X
BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
[TBL] [Abstract] [Full Text] [Related]
12. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
13. Expression and clinical significance of PD-1 in UCEC and its Impact on tumor.
Xing F; Yang Y; Zheng W
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):168-173. PubMed ID: 37571885
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
15. MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis.
Zhang Y; Wang J; Fan Y; Lang F; Fu F; Liu Q
Clin Transl Oncol; 2024 Mar; 26(3):653-663. PubMed ID: 37523078
[TBL] [Abstract] [Full Text] [Related]
16. High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma.
Hao J; Liu T; Xiu Y; Yuan H; Xu D
Front Immunol; 2023; 14():1208223. PubMed ID: 37388735
[TBL] [Abstract] [Full Text] [Related]
17. Asparanin A exerts cytotoxicity on human endometrial cancer Ishikawa cells via regulating miR-6236-p5_4 expression.
Zhang F; Zhang XX; Zhang JG; Thakur K; Simal-Gandara J; Prieto MA; Khan MR; Cao H; Wei ZJ
Food Chem Toxicol; 2023 Aug; 178():113900. PubMed ID: 37369310
[TBL] [Abstract] [Full Text] [Related]
18. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
19. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
[TBL] [Abstract] [Full Text] [Related]
20. ITGA5 promotes tumor angiogenesis in cervical cancer.
Xu X; Shen L; Li W; Liu X; Yang P; Cai J
Cancer Med; 2023 May; 12(10):11983-11999. PubMed ID: 36999964
[TBL] [Abstract] [Full Text] [Related]
[Next]
